These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9832288)

  • 1. The anti-lipase activity of shiunko on Propionibacterium acnes.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T
    Int J Antimicrob Agents; 1998 Aug; 10(3):251-2. PubMed ID: 9832288
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M; Cho O; Sugita T
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
    Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
    J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of macrolide therapy on patients with acne vulgaris].
    Akamatsu H
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():109-12. PubMed ID: 11439886
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sub-lethal concentrations of the antimicrobial agent propylene phenoxetol on the growth and extracellular enzymes of Propionibacterium acnes.
    Greenman J
    Microbios; 1984; 39(156):101-8. PubMed ID: 6231455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipases: their questionable role in acne vulgaris.
    Fulton JE
    Int J Dermatol; 1976 Dec; 15():732-7. PubMed ID: 136423
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA; Voss JG
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of sebum production and Propionibacterium acnes lipase activity by fullerenol, a novel polyhydroxylated fullerene: potential as a therapeutic reagent for acne.
    Inui S; Aoshima H; Ito M; Kobuko K; Itami S
    J Cosmet Sci; 2012; 63(4):259-65. PubMed ID: 23193890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
    Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes.
    Wunnoo S; Saising J; Voravuthikunchai SP
    Anaerobe; 2017 Feb; 43():61-68. PubMed ID: 27923605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipolytic activity of microorganisms in acne vulgaris.
    Cunliffe WJ; Strangfeld K; Holland KT; Roberts CD; Edwards JC
    Proc R Soc Med; 1975 May; 68(5):275-6. PubMed ID: 129776
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of coptidis rhizoma to lipase activity of Propionibacterium acnes].
    Higaki S; Hasegawa Y; Morohashi M; Sakamoto K; Yamagishi T
    Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):883-6. PubMed ID: 2232295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
    Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
    J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular pH and the development of acne.
    Greenman J
    Int J Dermatol; 1981 Dec; 20(10):656-8. PubMed ID: 6460005
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance of Propionibacterium acnes in acne vulgaris.
    Swanson JK
    Dermatol Nurs; 2003 Aug; 15(4):359-62. PubMed ID: 14515616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.